Mark G. Jones

7.7k citations
70 papers · 3.3k · 3 hit papers · h-index 20

Impact in

    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
    • Chronic Obstructive Pulmonary Disease (COPD) Research
    • Occupational and environmental lung diseases
    • Medical Imaging and Pathology Studies
    • Neonatal Respiratory Health Research
    • Inhalation and Respiratory Drug Delivery
  • Neurology top 5%
    • Long-Term Effects of COVID-19

Papers in

    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 32
    • Medical Imaging and Pathology Studies 11
    • Occupational and environmental lung diseases 10
    • Sarcoidosis and Beryllium Toxicity Research 14

Mark G. Jones

67 papers receiving 3.2k citations

Hit Papers

3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study 2021 · 433 citations
4330+3+6Years since publication4008001.2k

Peers

Mark G. Jones
Comparison fields: 5 of 129
  • Pulmonary and Respiratory Medicine 2.3k
  • Neurology 420
  • Critical Care and Intensive Care Medicine 124
  • Physiology 397
  • Infectious Diseases 251
Replace Kenji Tsushima with:
Kenji Tsushima Japan
Nazia Chaudhuri United Kingdom
Peter I. Bonta Netherlands
Mark E. Wylam United States
Mario Santini Italy
Giuseppe Francesco Sferrazza Papa Italy
Geoffrey B. Johnson United States
Francesco Facciolo Italy
Helge Røsjø Norway
Alfonso Fiorelli Italy
Mark G. Jones relative to Kenji Tsushima Japan Kenji Tsushima's profile →
Citations per field
00.5×5.2×
Kenji Tsushima · 1×
Citations per year

Countries citing papers authored by Mark G. Jones

Since Specialization
Citations

This map shows the geographic impact of Mark G. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark G. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark G. Jones more than expected).

Fields of papers citing papers by Mark G. Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark G. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark G. Jones. The network helps show where Mark G. Jones may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark G. Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark G. Jones Line = papers co-authored together Mark G. Jones links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Idiopathic pulmonary fibrosis
Hit paper breakdown →
20171379
2
3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study
Hit paper breakdown →
2021433
3
Idiopathic pulmonary fibrosis: Disease mechanisms and drug development
Hit paper breakdown →
2020392
4 2019127
5 2019110
6 198488
7 201670
8 201965
9 201943
10 200541
11 201838
12 202133
13 202229
14 202028
15 201826
16 200525
17 200423
18 202122
19 202122
20 201022

About Mark G. Jones

Mark G. Jones is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Molecular Biology, Rheumatology and Infectious Diseases, having authored 70 papers that have together received 3.3k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (32 papers), Sarcoidosis and Beryllium Toxicity Research (14 papers), Medical Imaging and Pathology Studies (11 papers), Occupational and environmental lung diseases (10 papers), Eosinophilic Disorders and Syndromes (5 papers), Microbial metabolism and enzyme function (4 papers), Metabolism and Genetic Disorders (4 papers) and Advanced Radiotherapy Techniques (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.3k citations), Neurology (420 citations), Critical Care and Intensive Care Medicine (124 citations), Physiology (397 citations) and Infectious Diseases (251 citations). Mark G. Jones has collaborated with scholars based in United Kingdom, Italy and United States. Frequent co-authors include Luca Richeldi, Harold R. Collard, Yihua Wang, Donna E. Davies, Toby M. Maher, Paolo Spagnolo, Joyce Lee, Christopher J. Ryerson, Argyrios Tzouvelekis and Giulio Rossi. Their work appears in journals such as Thorax, Respirology, Journal of Inherited Metabolic Disease, ERJ Open Research and Clinica Chimica Acta.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact